Your browser doesn't support javascript.
Effect Evaluation of Echocardiography on Right Ventricular Function in Patients after the Recovering from Coronavirus Disease 2019.
Yang, Jianqing; Liu, Ping; Zhong, Mang; Luo, Ting; Lei, Guolong; Liao, Chunfeng.
  • Yang J; Department of Ultrasound, Changsha First Hospital, Changsha, 410005 Hunan, China.
  • Liu P; Respiratory and Critical Care Center, Changsha First Hospital, Changsha 410005, China.
  • Zhong M; Department of Ultrasound, Changsha First Hospital, Changsha, 410005 Hunan, China.
  • Luo T; Department of Ultrasound, Changsha First Hospital, Changsha, 410005 Hunan, China.
  • Lei G; Department of Ultrasound, Changsha First Hospital, Changsha, 410005 Hunan, China.
  • Liao C; Department of Cardiovascular Medicine, Changsha First Hospital, Changsha, 410005 Hunan, China.
Comput Math Methods Med ; 2022: 6161015, 2022.
Article in English | MEDLINE | ID: covidwho-1938097
ABSTRACT
This research was aimed at exploring the changes in right ventricular function in patients after the recovery of coronavirus disease 2019 (COVID-19) under echocardiography and providing a reference for the rehabilitation and treatment of COVID-19 patients. Three echocardiographic follow-up examinations were performed on 40 recovered COVID-19 patients and 40 healthy people. Right ventricular function between patients after COVID-19 rehabilitation and healthy people was compared. The mean values of right ventricular fractional area change (RVFAC), tricuspid annular plane systolic excursion (TAPSE), right ventricular ejection fraction (RVEF), right myocardial performance index (RMPI), and tricuspid annular plane systolic speed (S') were compared between patients after COVID-19 rehabilitation and healthy subjects. The technical parameters of two-dimensional speckle tracking were compared. The results showed that the differences in RVFAC, TAPSE, RVEF, and RMPI between COVID-19 patients and healthy controls were not significant during the three follow-up periods (P > 0.05). At the first follow-up, the S' was 12.78 cm/s in COVID-19 patients and 13.18 cm/s in healthy subjects. At the second follow-up, the S' was 11.98 cm/s in COVID-19 patients and 12.77 cm/s in healthy subjects. At the third follow-up, the S' was 12.79 cm/s in COVID-19 patients and 13.12 cm/s in healthy subjects. There was no significant difference between the two groups (P > 0.05). In addition, there was no significant difference in right ventricular function between COVID-19 patients and healthy controls, and there was no significant difference in cardiovascular symptoms (P > 0.05). In summary, COVID-19 had no substantial effect on right ventricular function and better recovery in patients.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ventricular Dysfunction, Right / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Comput Math Methods Med Journal subject: Medical Informatics Year: 2022 Document Type: Article Affiliation country: 2022

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ventricular Dysfunction, Right / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Comput Math Methods Med Journal subject: Medical Informatics Year: 2022 Document Type: Article Affiliation country: 2022